As Canada approaches its first year with legalized cannabis, scientists across the country are still studying the drug without a consensus on what constitutes a standard dose.
That is problematic from a research perspective because results from one study are very difficult to test in another trial without an agreed-upon dose that remains consistent across different experiments, according to Stephanie Lake, a scientist with the BC Centre on Substance Use, an organization funded by the provincial government to study drugs. Plus, the reaction to one gram of cannabis with 10-per-cent THC – the plant’s most prominent psychoactive compound – can be very different depending on whether it is smoked in a joint, vaped, or ingested in an oil.
Click here to read the article on The Globe and Mail.
